Cabometyx is under clinical development by Exelixis and currently in Phase II for Salivary Gland Cancer. According to GlobalData, Phase II drugs for Salivary Gland Cancer have a 14% phase transition ...

Alphaf-001 is under clinical development by Alpha Fusion and currently in Phase I for Papillary Thyroid Cancer.

Dr Ahmed, who is based in the UK, said it was "very rare" to get thyroid cancer but it has become "more common" and he is ...

Madison LeCroy and Brett Randle are sharing an update on Brett's thyroid cancer diagnosis and ongoing health complications. During Season 10, Episode 4 of Southern Charm, the married couple had a ...

Donald Trump accompanied his wife in a black tuxedo. A high-impact winter storm is expected to affect the region from ...

Hormones do a lot throughout a person’s lifespan. Most people associate hormones with development and sex. Learn about their ...

Radioiodine therapy was non-inferior to no radioiodine therapy after thyroidectomy among patients with low-risk ...

But instead of joining a gym, why not pledge to take care of yourself by reducing your risk for cancer.Dr. Todd Pezzi, a board-certified radiation oncologist at Advocate Radiation Oncology, joined ...

Young adults face rising cancer rates — and barriers to timely interventions. From now until the end of the year, all ...

A NEW study highlights the significant health implications for patients with primary Sjögren’s syndrome (pSS) who also have thyroid diseases (TD). Researchers found that this dual diagnosis is ...

We work right across the cancer research pathway with strengths ranging from cell biology to healthcare research. We aim to nurture the thought leaders of today and tomorrow through the provision of ...

A total of 2,303 participants (81.3%) received a diagnosis of papillary thyroid cancer (PTC), and 530 (18.7%) had other subtypes of thyroid cancer. Figure 5. Forest plots comparing SIR rates between ...